MITIGASI FRAUDULENT FINANCIAL STATEMENT MELALUI PENERAPAN GOOD CORPORATE GOVERNANCE: BUKTI EMPIRIS PADA INDUSTRI FARMASI DI INDONESIA
Jurnal Ekonomi Pembangunan STIE Muhammadiyah Palopo · 03.07.2026 · 12 (1) · 139
DOI: 10.35906/jep.v12i1.2908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Ekonomi Pembangunan STIE Muhammadiyah Palopo, online erschienen am 03.07.2026. Verfasst von Berliana Aini Fitria und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Financial statement fraud remains a significant concern because it compromises the reliability of financial information, potentially leading to inappropriate decisions by investors, creditors, and other stakeholders. This study investigates the effect of Good Corporate Governance (GCG) and corporate complexity on fraudulent financial
Zitieren
APA
Fitria, B. A., & Budiwitjaksono, G. S. (2026). MITIGASI FRAUDULENT FINANCIAL STATEMENT MELALUI PENERAPAN GOOD CORPORATE GOVERNANCE: BUKTI EMPIRIS PADA INDUSTRI FARMASI DI INDONESIA. Jurnal Ekonomi Pembangunan STIE Muhammadiyah Palopo, 12(1), 139. https://doi.org/10.35906/jep.v12i1.2908
Vancouver
Fitria BA, Budiwitjaksono GS. MITIGASI FRAUDULENT FINANCIAL STATEMENT MELALUI PENERAPAN GOOD CORPORATE GOVERNANCE: BUKTI EMPIRIS PADA INDUSTRI FARMASI DI INDONESIA. Jurnal Ekonomi Pembangunan STIE Muhammadiyah Palopo. 2026;12(1):139. doi:10.35906/jep.v12i1.2908
BibTeX
@article{Fitria2026,
author = {Fitria, Berliana Aini and Budiwitjaksono, Gideon Setyo},
title = {MITIGASI FRAUDULENT FINANCIAL STATEMENT MELALUI PENERAPAN GOOD CORPORATE GOVERNANCE: BUKTI EMPIRIS PADA INDUSTRI FARMASI DI INDONESIA},
journal = {Jurnal Ekonomi Pembangunan STIE Muhammadiyah Palopo},
year = {2026},
volume = {12},
number = {1},
pages = {139},
doi = {10.35906/jep.v12i1.2908}
}
EUVIMED